Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine

Bosch A, Poglitsch M, Kannenkeril D, Ott C, Striepe K, Schmieder R (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Diabetologia Springer Verlag (Germany)

Publisher: SPRINGER

City/Town: NEW YORK

Pages Range: 256-256

Conference Proceedings Title: DIABETOLOGIA

Authors with CRIS profile

Agnes Bosch Department of Medicine 4 – Nephrology and Hypertension Christian Ott Department of Medicine 4 – Nephrology and Hypertension Kristina Striepe Professur für Innere Medizin (Nephrologie) Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

Attoquant Diagnostics GmbH DE Germany (DE)

How to cite

APA:

Bosch, A., Poglitsch, M., Kannenkeril, D., Ott, C., Striepe, K., & Schmieder, R. (2021). Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine. In DIABETOLOGIA (pp. 256-256). NEW YORK: SPRINGER.

MLA:

Bosch, Agnes, et al. "Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine." Proceedings of the DIABETOLOGIA NEW YORK: SPRINGER, 2021. 256-256.

BibTeX: Download